secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2022-12-30T23:59:59+00:00
Accession:  0000950170-22-027117
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics draws $15M second tranche under $45M loan facility with Avenue Venture
--------------------------------------------------------------------------------

- Completed $15M draw on Dec 29, 2022, as second tranche of $30M committed under Aug 8, 2022 Loan Agreement.
- Total facility provides up to $45M in term loans; $15M was funded at closing, $15M now drawn.
- Loan from Avenue Venture Opportunities Fund; terms previously filed and unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000095017022027117/0000950170-22-027117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000095017022027117/rani-20221229.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-027117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer